NCAB Task Force Urges New Study Section For Clinical Cancer Research, Sees “Crisis”
In Brief: Henderson Names to HHA Post; Nurses Support Cigarette Tax Increase; FDA Staff Changes
Komen Foundation Shifts Emphasis To Underserved
Clinton Budget For NIH “Disappointing,” AACR executive Director Says
ACS Expresses Concern About “Fletcher Report” On Mammography
FDA Ceases Exclusion Of Women From Early Drug Studies
ACS Encourages Grant Applications In All Aspects Of Pain Control
Trending Stories
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Cancer Center at Illinois is recognized as NCI Basic Cancer Center, becoming the first new institution to earn this designation in 40 years
- Most Favored Nation drug pricing could put China on top
- NCI Director Letai wants you to know: Grant money is flowing again post-government shutdown
- Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
A kit for at-home unsupervised self-collection clears FDA finish line
